• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA m6A 修饰在肝脏生物学中的作用及其在肝脏疾病和癌症发生中的意义。

RNA m6A modification in liver biology and its implication in hepatic diseases and carcinogenesis.

机构信息

Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana.

出版信息

Am J Physiol Cell Physiol. 2022 Oct 1;323(4):C1190-C1205. doi: 10.1152/ajpcell.00214.2022. Epub 2022 Aug 29.

DOI:10.1152/ajpcell.00214.2022
PMID:36036444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9576175/
Abstract

N6-methyladenosine (m6A) is the most prevalent internal modification in eukaryotic RNAs. This modification is regulated by three different factors (writers, erasers, and readers) and affects multiple aspects of RNA metabolism, including RNA splicing, nuclear export, translation, stability and decay. The m6A-mediated modification plays important roles in posttranscriptional regulation of gene expression and mediates a variety of cellular and biological processes. Accordingly, deregulation in m6A modification is closely related to the occurrence and development of human diseases. The liver is the largest digestive and metabolic organ in human and recent studies have shown that m6A modification is importantly implicated in liver cellular and physiological functions and in the pathogenesis of hepatic diseases and cancers. In the current review, we summarize the functions of m6A in RNA metabolism and its roles in liver cell biology and discuss its implication in hepatic diseases and carcinogenesis.

摘要

N6-甲基腺苷(m6A)是真核 RNA 中最普遍的内部修饰。这种修饰受三种不同的因素(writers、erasers 和 readers)调控,并影响 RNA 代谢的多个方面,包括 RNA 剪接、核输出、翻译、稳定性和降解。m6A 介导的修饰在基因表达的转录后调控中起着重要作用,并介导多种细胞和生物过程。因此,m6A 修饰的失调与人类疾病的发生和发展密切相关。肝脏是人体最大的消化和代谢器官,最近的研究表明,m6A 修饰在肝细胞的生理功能以及肝脏疾病和癌症的发病机制中起着重要作用。在本综述中,我们总结了 m6A 在 RNA 代谢中的功能及其在肝细胞核生物学中的作用,并讨论了其在肝脏疾病和癌症发生中的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1331/9576175/a26a9afa8f47/c-00214-2022r01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1331/9576175/a26a9afa8f47/c-00214-2022r01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1331/9576175/a26a9afa8f47/c-00214-2022r01.jpg

相似文献

1
RNA m6A modification in liver biology and its implication in hepatic diseases and carcinogenesis.RNA m6A 修饰在肝脏生物学中的作用及其在肝脏疾病和癌症发生中的意义。
Am J Physiol Cell Physiol. 2022 Oct 1;323(4):C1190-C1205. doi: 10.1152/ajpcell.00214.2022. Epub 2022 Aug 29.
2
Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.环状 RNA 和 N6-甲基腺苷(m6A)修饰对癌症生物学的影响。
Biomed Pharmacother. 2023 Mar;159:114260. doi: 10.1016/j.biopha.2023.114260. Epub 2023 Jan 17.
3
Pathogenic Roles of m6A Modification in Viral Infection and Virus-driven Carcinogenesis.m6A 修饰在病毒感染和病毒驱动的致癌作用中的致病作用。
Endocr Metab Immune Disord Drug Targets. 2022;22(10):1009-1017. doi: 10.2174/2772432817666220412112759.
4
N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.N6-甲基腺苷RNA修饰:中枢神经系统损伤中一个有前景的调节因子。
Exp Neurol. 2021 Nov;345:113829. doi: 10.1016/j.expneurol.2021.113829. Epub 2021 Jul 31.
5
Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues.m6A 与癌症中编码/非编码 RNA 的串扰及其修饰残基的检测方法。
Aging (Albany NY). 2023 Jul 11;15(13):6577-6619. doi: 10.18632/aging.204836.
6
m6A RNA Methylation and Implications for Hepatic Lipid Metabolism.m6A RNA 甲基化及其对肝脂代谢的影响。
DNA Cell Biol. 2024 Jun;43(6):271-278. doi: 10.1089/dna.2023.0410. Epub 2024 Apr 18.
7
The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.N6-甲基腺苷(m6A)失调在肝癌发生中的新作用。
Mol Cancer. 2020 Feb 28;19(1):44. doi: 10.1186/s12943-020-01172-y.
8
Function of N6-Methyladenosine Modification in Tumors.N6-甲基腺苷修饰在肿瘤中的作用
J Oncol. 2021 Nov 23;2021:6461552. doi: 10.1155/2021/6461552. eCollection 2021.
9
N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment.N6-甲基腺苷 RNA 甲基化在肝脏疾病中的作用:从机制到治疗。
J Gastroenterol. 2023 Aug;58(8):718-733. doi: 10.1007/s00535-023-02008-4. Epub 2023 Jun 28.
10
Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.主要的N6-甲基腺苷识别蛋白:癌症中的YTH家族蛋白
Front Oncol. 2021 Apr 13;11:635329. doi: 10.3389/fonc.2021.635329. eCollection 2021.

引用本文的文献

1
Emerging Concepts in Immuno-Oncology: Insights from Natural Language Processing-Driven Co-Occurrence Analysis.免疫肿瘤学中的新兴概念:来自自然语言处理驱动的共现分析的见解
ACS Omega. 2025 Jun 27;10(27):28587-28614. doi: 10.1021/acsomega.5c00693. eCollection 2025 Jul 15.
2
Treadmill Exercise-Induced RNA m6A Methylation Modification in the Prevention of High-Fat Diet-Induced MASLD in Mice.跑步机运动诱导的RNA m6A甲基化修饰对预防小鼠高脂饮食诱导的MAFLD的作用
Int J Mol Sci. 2025 Jun 17;26(12):5810. doi: 10.3390/ijms26125810.
3
Role, mechanism, and application of N6-methyladenosine in hepatobiliary carcinoma.

本文引用的文献

1
N6-methyladenosine (m6A) modification in gynecological malignancies.N6-甲基腺苷(m6A)修饰在妇科恶性肿瘤中的作用。
J Cell Physiol. 2022 Sep;237(9):3465-3479. doi: 10.1002/jcp.30828. Epub 2022 Jul 8.
2
Liver-specific Mettl3 ablation delays liver regeneration in mice.肝脏特异性Mettl3基因敲除会延迟小鼠肝脏再生。
Genes Dis. 2020 Nov 13;9(3):697-704. doi: 10.1016/j.gendis.2020.11.002. eCollection 2022 May.
3
Nuclear Aurora kinase A switches mA reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4.
N6-甲基腺苷在肝胆癌中的作用、机制及应用
World J Gastrointest Oncol. 2025 Jun 15;17(6):105140. doi: 10.4251/wjgo.v17.i6.105140.
4
Pan-cancer analysis of DLAT reveals it as a prognostic Biomarker involved in immune infiltration of liver hepatocellular carcinoma.DLAT的泛癌分析表明其作为一种预后生物标志物参与肝细胞癌的免疫浸润。
J Cancer. 2025 Mar 21;16(7):2167-2180. doi: 10.7150/jca.102256. eCollection 2025.
5
RNA Modification in Metabolism.新陈代谢中的RNA修饰
MedComm (2020). 2025 Mar 10;6(3):e70135. doi: 10.1002/mco2.70135. eCollection 2025 Mar.
6
METTL3-Mediated m6A Modification Regulates the Polycomb Repressive Complex 1 Components BMI1 and RNF2 in Hepatocellular Carcinoma Cells.METTL3介导的m6A修饰调控肝癌细胞中多梳抑制复合物1组分BMI1和RNF2
Mol Cancer Res. 2025 Mar 3;23(3):190-201. doi: 10.1158/1541-7786.MCR-24-0362.
7
Notch-Driven Cholangiocarcinogenesis Involves the Hippo Pathway Effector TAZ via METTL3-m6A-YTHDF1.Notch驱动的胆管癌发生通过METTL3-m6A-YTHDF1涉及Hippo信号通路效应分子TAZ。
Cell Mol Gastroenterol Hepatol. 2025;19(1):101417. doi: 10.1016/j.jcmgh.2024.101417. Epub 2024 Oct 5.
8
METTL3 Deficiency Aggravates Hepatic Ischemia/Reperfusion Injury in Mice by Activating the MAPK Signaling Pathway.METTL3 缺乏通过激活 MAPK 信号通路加剧小鼠肝缺血/再灌注损伤。
Int J Med Sci. 2024 Apr 15;21(6):1037-1048. doi: 10.7150/ijms.94177. eCollection 2024.
9
Comprehensive analysis of mA methylome alterations after azacytidine plus venetoclax treatment for acute myeloid leukemia by nanopore sequencing.通过纳米孔测序对阿扎胞苷联合维奈克拉治疗急性髓系白血病后的mA甲基化组改变进行综合分析。
Comput Struct Biotechnol J. 2024 Mar 2;23:1144-1153. doi: 10.1016/j.csbj.2024.02.029. eCollection 2024 Dec.
10
Nitric oxide inhibits FTO demethylase activity to regulate N-methyladenosine mRNA methylation.一氧化氮抑制 FTO 去甲基酶活性以调节 N-甲基腺苷 mRNA 甲基化。
Redox Biol. 2023 Nov;67:102928. doi: 10.1016/j.redox.2023.102928. Epub 2023 Oct 14.
核极光激酶 A 将 mA 读码器 YTHDC1 切换,以增强肿瘤抑制因子 RBM4 的致癌 RNA 剪接。
Signal Transduct Target Ther. 2022 Apr 1;7(1):97. doi: 10.1038/s41392-022-00905-3.
4
METTL14 promotes prostate tumorigenesis by inhibiting THBS1 via an m6A-YTHDF2-dependent mechanism.METTL14通过一种m6A - YTHDF2依赖的机制抑制THBS1,从而促进前列腺肿瘤发生。
Cell Death Discov. 2022 Mar 30;8(1):143. doi: 10.1038/s41420-022-00939-0.
5
Insight into the structure, physiological function, and role in cancer of m6A readers-YTH domain-containing proteins.对m6A阅读蛋白(含YTH结构域蛋白)的结构、生理功能及其在癌症中的作用的深入了解。
Cell Death Discov. 2022 Mar 28;8(1):137. doi: 10.1038/s41420-022-00947-0.
6
METTL3-mediated maturation of miR-589-5p promotes the malignant development of liver cancer.METTL3 介导的 miR-589-5p 成熟促进肝癌的恶性发展。
J Cell Mol Med. 2022 May;26(9):2505-2519. doi: 10.1111/jcmm.16845. Epub 2022 Mar 29.
7
N6-Methyladenosine Modification Participates in the Progression of Hepatitis B Virus-Related Liver Fibrosis by Regulating Immune Cell Infiltration.N6-甲基腺苷修饰通过调节免疫细胞浸润参与乙型肝炎病毒相关肝纤维化的进展。
Front Med (Lausanne). 2022 Mar 2;9:821710. doi: 10.3389/fmed.2022.821710. eCollection 2022.
8
The XRN1-regulated RNA helicase activity of YTHDC2 ensures mouse fertility independently of mA recognition.YTHDC2 的 XRN1 调节的 RNA 解旋酶活性确保了小鼠的生育能力,而不依赖于 mA 的识别。
Mol Cell. 2022 May 5;82(9):1678-1690.e12. doi: 10.1016/j.molcel.2022.02.034. Epub 2022 Mar 18.
9
Modification of STIM2 by mA RNA methylation inhibits metastasis of cholangiocarcinoma.通过 mA RNA 甲基化修饰 STIM2 可抑制胆管癌转移。
Ann Transl Med. 2022 Jan;10(2):40. doi: 10.21037/atm-21-6485.
10
Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma.miR-362-3p/miR-425-5p 下调 ZC3H13 的表达与肝癌患者预后不良及不良结局相关。
Aging (Albany NY). 2022 Mar 12;14(5):2304-2319. doi: 10.18632/aging.203939.